Featured Articles

  1. Helping Quiet Life Science Leaders Be Seen, Heard, And Valued 8/5/2025

    Executive coach Joel Garfinkle shares tips to help "quiet" life science leaders assert themselves and move from invisible to influential within their organizations.

  2. From Scientific Discovery To Next Generation Treatments For Obesity 7/31/2025

    Twenty years ago, Roger Cone, Ph.D. made a key discovery in obesity science which could help Courage Therapeutics deliver products that improve upon currently available treatments for obesity.

  3. What Life Sciences Companies Can Learn From BMW and Volkswagen 7/30/2025

    Life sciences companies can look to the automotive industry for ideas about collaborating with patients to co-create new products, write Noël Theodosiou and Patrick O. Gee.

  4. Open Science And A Robust IP Strategy: Life Sciences Can Do Both 7/28/2025

    By sharing early-stage tools and data openly, life sciences companies can minimize duplication and de-risk R&D without risking exclusive rights over valuable assets, writes Richard Gold.

  5. All Of Us Need To Be Rooting For The FDA 7/23/2025

    In light of FDA leadership changes and operational updates, FDA Matters' Steven Grossman asks us all to slow down and consider why we should be cheering on, not tearing down, the present-day FDA.

  6. Why So Many Biotech Launches Miss Expectations, And How To Fix It 7/18/2025

    More than half of drug launches fall short of forecasts. Engaging payers during trial design and capturing outcomes with real world impacts, among other things, can help, explains Bennett Smith.

  7. Life Sciences 2025 2H Trends: Regulations, Precision Medicine, Oncology Investment 7/16/2025

    What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and private equity investment in oncology, according to experts at KPMG.

  8. IP Law: In Defense Of Polymorphs 7/15/2025

    Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent court ruling, however, adds new complexity, write experts at Finnegan.

  9. Epic Bio's Big Swing In Epigenetic Editing 7/11/2025

    Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about epigenetic editing, working with the FDA, using AI for clinical endpoints, and more.

  10. Building Biotech Champions: Cultivating Breakthroughs In A Dynamic Field 7/10/2025

    Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.